CD4 and rheumatoid arthritis: However, other studies have shown no defects in the suppressive capacity of CD4+CD25high Treg cells from patients with early, active RA who were being treated with steroids and were DMARD‐naive, as compared to patients who were being treated with DMARDs and had well‐controlled disease or healthy controls 5, 7.